Ambrosia Biosciences develops orally delivered, small molecule-based therapies for obesity and metabolic disorders.

Symmera provides scalable, secure device management solutions using a zero-trust architecture and quantum-proof cryptography.

Ambrosia Biosciences develops orally delivered, small molecule-based therapies for obesity and metabolic disorders.

ClinOne is a technology platform provider for global clinical trials that connects, informs, and empowers patients, care partners, and sites, and has raised an additional $2M in its Series A funding round to expand operations and business reach.